Researcher charges Anthera held key data from failed heart drug study
November 19, 2013 at 15:12 PM EST
Anthera Pharmaceuticals Inc. has lost more than 6 percent of its value this week, following charges that the company delayed disclosing data showing that patients in a failed heart drug trial were more likely to suffer from heart attacks and strokes...